VitaDAO representatives Arthur Hayes and Paul Kohlhaas will take the stage at the DeSci Singapore conference. This one-day event in Singapore will focus on AI agents, the tokenization of intellectual property, and decentralized clinical trials, featuring live demonstrations. As Web3 technologies advance, these areas are emerging as key drivers of biotech innovation, enhancing transparency and efficiency in medical research.
this-content
disclaimer-th
1H | 24H | 7D | 30D | 1Y |
---|---|---|---|---|
-- | -- | -- | -- | -- |